Indutrade AB (INDT)
Stockholm Exchange · Sweden · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 247.60 |
|---|---|
| 52-week range | 180.70 – 272.20 |
| Return, 1 month / 3 months | −2.4% / +3.0% |
| Return, 1 year / 3 years | −3.6% / +35.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 37 |
| Volatility (1 year) | 35.7% |
| Worst drawdown (1 year) | -30.2% |
| Average daily value traded | 89.65M SEK |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Indutrade is a Swedish industrial group that owns a large collection of autonomous businesses. Its companies supply components, systems and services in areas such as flow technology, industrial components, special products and measurement equipment. Customers are mainly industrial firms and other professional buyers across Europe and beyond, and each subsidiary keeps its own brand and local management while the parent provides financial backing and long-term ownership. The group is based in Sweden.
The shares are listed on the Stockholm Exchange in Sweden under the code INDT, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Indutrade AB (INDT) trades on the Stockholm Exchange in Sweden. It last closed at SEK 247.60 on 23 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 173 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.6% and over the last three months it rose 3.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.0% | ||
| From 52-week high | -8.6% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.0% | ||
| 6-month return | -1.6% | ||
| 12-month return, skipping the last month | -1.2% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.2% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 89.65M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −8.6% |
|---|---|
| 1 month | −2.4% |
| 3 months | +3.0% |
| 6 months | −1.6% |
| 1 year | −3.6% |
| 3 years | +35.9% |
| 5 years | +4.2% |
Signals
| 50-day / 200-day average | 252.82 / 225.01 |
|---|---|
| Golden / death cross (60 days) | Golden, 47 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.01 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2026 | SEK 3.1000 |
| 4 Apr 2025 | SEK 3.0000 |
| 10 Apr 2024 | SEK 2.8500 |
| 30 Mar 2023 | SEK 2.6000 |
| 6 Apr 2022 | SEK 2.3000 |
| 14 Apr 2021 | SEK 1.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.